NASDAQ
Eupraxia Pharmaceuticals Inc. (EPRX) has a fcf yield of -9.82% as of Monday, August 3, 2026. This represents a 57.03% increase compared to its 12-month average of -22.86%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.